G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/48 (2006.01) A61K 31/52 (2006.01) A61P 1/04 (2006.01) G01N 30/02 (2006.01)
Patent
CA 2345100
The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
Procédé permettant d'optimiser l'efficacité thérapeutique et de réduire la toxicité associée au traitement médicamenteux à base de 6-mercaptopurine d'une maladie gastro-intestinale à médiation immune, telle que la maladie intestinale inflammatoire. Le procédé selon la présente invention consiste à déterminer le taux d'un ou plusieurs métabolites de 6-mercaptopurine chez le patient souffrant d'une maladie gastro-intestinale à médiation immune.
Seidman Ernest G.
Theoret Yves
Hopital Sainte-Justine
Smart & Biggar
LandOfFree
Optimized use of 6-mercaptopurine drug in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optimized use of 6-mercaptopurine drug in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optimized use of 6-mercaptopurine drug in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1825366